Scientists study rare blindness to pave way for gene therapy
NCT ID NCT04639635
First seen Jan 11, 2026 · Last updated May 22, 2026 · Updated 24 times
Summary
This study looks at a rare form of retinitis pigmentosa caused by changes in the CNGB1 gene. Researchers want to understand how vision loss progresses over 3 years in 20 people. The goal is to find the best tests to measure the disease, so they can use them in a future gene therapy trial. This study does not offer treatment, but it is an important step toward developing one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINITIS PIGMENTOSA ASSOCIATED WITH CNGB1 MUTATIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dr. Stephen H. Tsang
New York, New York, 10032, United States
-
Eberhard Karls University Tubingen
Tübingen, Germany
-
Institut de la Vision/Centre de maladies rares du Centre Hospitalier National Ophtalmologique des Quinze-Vingts
Paris, France
-
Klinikum der Universität München University Eye Hospital, Ludwig-Maximilians-University (LMU) Munich
München, Bavaria, 80336, Germany
-
Moorfields Eye Hospital NHS Foundation Trust
London, United Kingdom
-
Wills Eye Hospital
Philadelphia, Pennsylvania, 19107, United States
Conditions
Explore the condition pages connected to this study.